- Home
- GRWG vs CGTX Comparison
GRWG vs CGTX Comparison
Compare GRWG & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRWG | CGTX |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.7M | 132.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GRWG | CGTX |
|---|---|---|
| Price | $1.79 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $2.50 | ★ $2.88 |
| AVG Volume (30 Days) | ★ 981.9K | 938.2K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $161,356,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.82 | $0.22 |
| 52 Week High | $2.40 | $3.83 |
Technical Indicators
Market Signals| Indicator | GRWG | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 46.12 |
| Support Level | $1.47 | $1.46 |
| Resistance Level | $2.40 | $1.61 |
| Average True Range (ATR) | 0.16 | 0.11 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 38.50 | 27.03 |
Price Performance
Historical ComparisonAbout GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.